---
figid: PMC9425441__ijms-23-08283-g007
figtitle: 'Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment,
  with a Focus on the Von Willebrand Factor and Factors VIII and V'
organisms:
- Mus musculus
- Rattus norvegicus
- Cricetulus griseus
- Bos taurus
- Sus scrofa
- Human immunodeficiency virus 1
- Severe acute respiratory syndrome coronavirus 2
- prion
- other sequences
- Homo sapiens
- Danio rerio
organisms_ner:
- Bos taurus
- Mus musculus
- Homo sapiens
- Sus scrofa
- Rattus norvegicus
- Cricetulus griseus
- Drosophila melanogaster
pmcid: PMC9425441
filename: ijms-23-08283-g007.jpg
figlink: /pmc/articles/PMC9425441/figure/ijms-23-08283-f007/
number: F7
caption: 'Homeostasis-modifying treatments in hemostasis. Replacement therapies: recombinant
  factors, fresh frozen plasma, Octaplas®, recombinant ADAMTS13, and adeno-associated
  viruses. Nonreplacement therapies: desmopressin; emicizumab; caplacizumab (anti-vWF);
  and immunomodulators, such as prednisone and rituximab. Rebalancing therapies: fitusiran,
  concizumab, marstacimab, and serpinPC. Anticoagulant therapies: DOACs. Antifibrinolytic
  therapies: tranexamic acid and β-aminocaproic acid. vWF, von Willebrand factor;
  FVIII, factor VIII; FV, factor V; FIX, factor IX; FX, factor X; TTP, thrombotic
  thrombocytopenic purpura; vWD, von Willebrand’s disease; FFP, fresh frozen plasma;
  AT-III, antithrombin III; TFPI, tissue factor pathway inhibitor; APC (PC), activated
  protein C; PS, protein S; DOACs, direct oral anticoagulants; rADAMTS13, recombinant
  ADAMTS13. (+), activation; (–), inhibition.'
papertitle: 'The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment,
  with a Focus on the Von Willebrand Factor and Factors VIII and V.'
reftext: Juan A. De Pablo-Moreno, et al. Int J Mol Sci. 2022 Aug;23(15):8283.
year: '2022'
doi: 10.3390/ijms23158283
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: vascular endothelium | coagulation | embryo | von Willebrand factor | factor
  VIII | factor V | homeostasis | coagulopathies | treatment
automl_pathway: 0.9523115
figid_alias: PMC9425441__F7
figtype: Figure
redirect_from: /figures/PMC9425441__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9425441__ijms-23-08283-g007.html
  '@type': Dataset
  description: 'Homeostasis-modifying treatments in hemostasis. Replacement therapies:
    recombinant factors, fresh frozen plasma, Octaplas®, recombinant ADAMTS13, and
    adeno-associated viruses. Nonreplacement therapies: desmopressin; emicizumab;
    caplacizumab (anti-vWF); and immunomodulators, such as prednisone and rituximab.
    Rebalancing therapies: fitusiran, concizumab, marstacimab, and serpinPC. Anticoagulant
    therapies: DOACs. Antifibrinolytic therapies: tranexamic acid and β-aminocaproic
    acid. vWF, von Willebrand factor; FVIII, factor VIII; FV, factor V; FIX, factor
    IX; FX, factor X; TTP, thrombotic thrombocytopenic purpura; vWD, von Willebrand’s
    disease; FFP, fresh frozen plasma; AT-III, antithrombin III; TFPI, tissue factor
    pathway inhibitor; APC (PC), activated protein C; PS, protein S; DOACs, direct
    oral anticoagulants; rADAMTS13, recombinant ADAMTS13. (+), activation; (–), inhibition.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ADAMTS13
  - ZFP36
  - VWF
  - SERPINC1
  - PC
  - Adamts13
  - Zfp36
  - Vwf
  - Serpinc1
  - Trim39
  - pc
  - Ps
  - SH3BP4
  - ATXN3
  - PGR-AS1
  - F10
  - TRIM39
  - INHCAP
  - F9
  - Ttpa
  - Agtr1b
  - Pc
  - ttp
  - se
  - ps
---
